Consortium Gets $7.2 M Contract Renewal To Promote Phase II Clinical Trials
Friday, October 28, 2011 - 12:00
in Health & Medicine
The National Cancer Institute recently awarded $7.2 million for the competitive renewal of the Southeast Phase 2 Consortium (SEP2C), led by Moffitt Cancer Center's Daniel Sullivan, M.D., executive vice president and associate center director for Clinical Investigations.